1,181 results on '"Pardi, Darrell S."'
Search Results
2. Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI
3. Diagnosis and Pharmacological Management of Microscopic Colitis in Geriatric Care
4. Inflammatory Bowel Disease: Therapy
5. Delayed Acute Pancreatitis After Transpapillary Gallbladder Drainage With Plastic Stents
6. Reduction in urinary tract infections in patients treated with fecal microbiota transplantation for recurrent Clostridioides difficile infection
7. Bile Acid Sequestrants in Microscopic Colitis: Clinical Outcomes and Utility of Bile Acid Testing
8. Clinical Characteristics and Treatment Response in Microscopic Colitis Based on Age at Diagnosis: A Multicenter Retrospective Study
9. Effectiveness of Bile Acid Sequestrants in Microscopic Colitis and Utility of Bile Acid Testing: A Systematic Review and Meta-Analysis
10. Management of pouch neoplasia: consensus guidelines from the International Ileal Pouch Consortium
11. The Epidemiology of Microscopic Colitis in Olmsted County, Minnesota: Population-Based Study From 2011 to 2019
12. Microscopic Colitis and Risk of Colon Adenomas: A Multicenter Retrospective Cohort Study
13. Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium
14. Efficacy and Safety of Vedolizumab and Tumor Necrosis Factor Inhibitors in the Treatment of Steroid-refractory Microscopic Colitis: A Systematic Review and Meta-analysis.
15. Effectiveness and Safety Profile of Budesonide Maintenance in Microscopic Colitis: A Systematic Review and Meta-Analysis.
16. Reply
17. Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium
18. Outcomes of Fecal Microbiota Transplantation for C. difficile Infection in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
19. S77 Safety and Efficacy of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) in Older Patients With Recurrent Clostridioides difficile Infection: Findings From an Integrated Analysis of Phase 3 Trials
20. S244 Open Label Experience With Bismuth Subsalicylate in Patients With Microscopic Colitis
21. S753 Clinical, Endoscopic and Histologic Features of Common Variable Immunodeficiency
22. S207 Predictive Machine Learning Models for Recurrent C. difficile Infection in Inflammatory Bowel Disease Patients Based on First-Episode CDI Treatment
23. S2404 Clinical Manifestations of Sclerosing Mesenteritis: A Case Series
24. S233 Clinical Outcomes and Safety Profile of Budesonide Maintenance in Microscopic Colitis: A Systematic Review and Meta-Analysis
25. S208 A Machine Learning Model for Predicting Recurrent C. difficile Infection in Patients With Inflammatory Bowel Disease (Recur CDI-IBD)
26. S206 Predicting Recurrent C. difficile Infection in IBD Patients: An Application of AutoML Tabular and Text Classification Models on Electronic Health Records and Clinical Notes
27. S3329 Delayed Acute Pancreatitis After Transpapillary Gallbladder Drainage With Plastic Stents, A Case Series
28. Microscopic colitis
29. Increasing antibiotic resistance in Clostridioides difficile: A systematic review and meta-analysis
30. Role of interventional inflammatory bowel disease in the era of biologic therapy: a position statement from the Global Interventional IBD Group
31. Validation of a CT-Derived Method for Osteoporosis Screening in IBD Patients Undergoing Contrast-Enhanced CT Enterography
32. Increased Risk of Acute Myocardial Infarction and Heart Failure in Patients With Inflammatory Bowel Diseases
33. Efficacy and Safety of Vedolizumab and Tumor Necrosis Factor Inhibitors in the Treatment of Steroid-refractory Microscopic Colitis
34. Low Risk of Primary Clostridium difficile Infection With Tetracyclines : A Systematic Review and Metaanalysis
35. Reply to Davido et al
36. Microscopic Colitis, Collagenous and Lymphocytic
37. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection Reduces Recurrent Urinary Tract Infection Frequency
38. Reliability among central readers in the evaluation of endoscopic disease activity in pouchitis
39. Non–Clostridium difficile Bacterial Infections Are Rare in Patients With Flares of Inflammatory Bowel Disease
40. Predictors and Management of Failed Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection
41. VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection
42. Use of Anti–Tumor Necrosis Factors and Anti-Integrins in the Treatment of Crohn's Disease
43. Experience and Outcomes at a Specialized Clostridium difficile Clinical Practice
44. Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression
45. The surgical management of inflammatory bowel disease
46. Chronic Diarrhea: Diagnosis and Management
47. Fidaxomicin treatment for Clostridioides difficile infection in patients with inflammatory bowel disease.
48. Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease
49. Clostridium difficile Infection in the Emergency Department
50. Chronic Diarrhea
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.